Acuity Pharmaceuticals' Reverse Merger Round

Acuity Pharmaceuticals raised a round of funding on March 28, 2007. Investors include OPKO Health.

OPKO Health, Inc. (Amex: OPK) today announced that a study published in the peer-reviewed journal Molecular Vision demonstrates that bevasiranib, its siRNA (small interfering RNA) agent is distributed…

Articles about Acuity Pharmaceuticals' Reverse Merger Round: